Belite Bio, Inc (BLTE) Tops Q4 EPS by 5c

Belite Bio, Inc (NASDAQ: BLTE) reported Q4 EPS of ($0.25), $0.05 better than the analyst estimate of ($0.30).

For earnings history and earnings-related data on Belite Bio, Inc (BLTE) click here.

You May Also Be Interested In

• NVIDIA stock gains as SemiAnalysis sees H2 data center revenue 20% above consensus
• US rail intermodal volumes surge 12.1% for sixth straight week of 5%+ gains
• Piper Sandler picks Payments and Consumer Finance winners as multiples reset